DIA 2023 Global Annual Meeting

June 25, 2023
June 29, 2023
Boston Convention & Exhibition Center 415 Summer Street Boston, MA 02210

The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, DIA 2023 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.

Join our interactive Innovation Theater and sessions to learn more about clinical trial technology and innovations. Make sure you stop by our booth #627 to see a demo to discover how our solutions can help accelerate your trials.

Click here to schedule a meeting with us at DIA Global Annual Meeting 2023

Session Information:

Session 1: Innovation Theater

Date: Tuesday, June 27th, 2023

Time: 9:45 a.m. – 10:15 a.m. EST

Location: Exhibit Hall Theater #2

This interactive panel will challenge how we bring inclusion to the forefront of flexible clinical trials. The audience will help us explore why clinical trials still lack diversity, despite years of focus and effort on inclusivity. Topics will include improving data collection while maintaining and enhancing integrity, identifying and encouraging diverse groups of people to take part in clinical trials, and reducing burdens that may be brought on by frequency and timing of data collection.


Todd Rudo headshot

Dr. Todd Rudo

Chief Medical Officer at Clario

Dr. Todd Rudo provides medical & scientific leadership and is passionate about leveraging scientific expertise to support our customers’ success, Dr. Rudo has focused on optimizing solutions across therapeutic areas. His team provided expert consulting services on scientific and regulatory strategy, and ensures our product portfolio is scientifically robust, generating high quality data to support clinical trial endpoints. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials. With nearly 20 years of clinical cardiology and pharmaceutical research experience, Dr. Rudo has focused predominantly on drug safety and has worked in various therapeutic areas.

Otis Johnson, Ph.D., MPA

Chief Diversity, Inclusion, and Sustainability Officer at Clario

Clario has a long history of ensuring diversity, inclusion and sustainability, something the organization is committed to improving under the leadership of Otis, who is Chief Diversity, Inclusion and Sustainability officer. He also works with employees, customers and shareholders to ensure they fulfil their environmental, governance and social responsibilities. With over 20 years’ experience of working in pharmaceuticals, Otis is passionate about the industry and holds expertise across clinical informatics, business analytics, sales, project management and research and development. He has held positions at a number of global companies including Merck, ICON and Syneos Health.

Kenneth Getz

Executive Director/Professor, Tufts CSDD; Founder/Board Chair, CISCRP and Tufts University School of Medicine, United States

Ken Getz is the Director and a professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine. He is also the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken also holds a number of board appointments in the private and public sectors. He received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University.

Karen Correa, Ph.D.

Vice President, Head of Global Clinical Operations at Takeda

Dr. Karen Correa is the Vice President, Head of Global Clinical Operations at Takeda; where she is responsible for the advancement of the portfolio and execution of global clinical trials. Her 30 years of clinical research experience cover a large range of settings and venues including, benchwork, clinical site, CRO, as well as both large and small pharma organizations and has spanned across multiple therapeutic areas. She also leads the “Diversity in Clinical Trials” at Takeda and is known as an SME on this topic for the past 25 years.  Dr. Correa serves as a board member of East Carolina University Alumni Board and CAMcare Health Corporation, a Federally Qualified Healthcare Center in South Jersey.

Session 2: Building Trust: Data Privacy in Decentralized Clinical Trials

Date: Monday, June 26th, 2023

Time: 1:30 p.m. – 2:30 p.m. EST

For the decentralized clinical trial modality to thrive, the data privacy concerns of multiple stakeholder groups must be addressed. This panel of industry luminaries will discuss how technology can continue to bring therapies to market faster while increasing diversity.

Learning Objectives:

Identify data privacy concerns from multiple perspectives: patient/participant, sponsor, innovator, technology provider; Determine how to meet all stakeholders’ needs for the sake of diversity, equity and inclusion; Describe how to increase stakeholders’ trust so that the clinical trials community can utilize new technologies such as decentralized clinical trials to bring life changing therapies to market faster.


Jay Ferro headshot

Jay Ferro

EVP, Chief Information, Product, & Technology Officer at Clario

Always striving for excellence, Jay heads up Clario’s development, information technology and strategic sourcing initiatives. With over 25 years’ experience of working as a global technology leader, Jay has a wealth of knowledge which helps drive changes that are critical to managing data protection. An expert in improving and implementing data policies, Jay is well placed to ensure the complete privacy and protection of data belonging to Clario’s customers and patients.

Session 3: The Importance of Having Clinical Data Managers as a Key Part of the Protocol Design Process

Presented during: Leveraging Data Scientists and Data Managers in Clinical Data Management Session

Date: Wednesday, June 28th, 2023

Time: 10:30 a.m. – 11:30 a.m. EST

Learning Objectives:

Describe the role of clinical data managers in the protocol design process: Discuss how to leverage data science and statistics principles, tools, and processes for clinical data management; Recognize need for wider organizational involvement for embracing data scientist function.


Joby John

Senior Director, Clinical Data Systems and Services at Clario

Dr. Joby John is a versatile Clinical Research executive with over 20 years of experience in managing end to end clinical services like EDC, CDM, SDTM, SAS, IWRS, eTMF to name a few. She has worked with a wide array of global Pharma companies, CROs and FSPs in setting up and managing multiple clinical domain teams. She is passionate about Clinical Data Management and its evolution and has presented/chaired sessions in multiple Industry forums like DIA and SCDM. Currently she is working as Senior Director, Clinical Data Systems and Services at Clario, based in Cary, North Carolina Dr. John is a dentist by education and attained her Bachelor of Dental Surgery at Rajiv Gandhi University of Health Sciences.

Meet with us at DIA Global Annual Meeting 2023.

Complete this form and we will reach out soon to schedule a time to connect at the event.

If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.